AVANCE vs MOLBIO: Stock Comparison
Head-to-head financial and trading comparison between Avance Technologies Limited (AVANCE) and Molbio Diagnostics Limited (MOLBIO) in the Cross-Sector Peers sector.
AVANCE
NSE: AVANCEMOLBIO
NSE: MOLBIOKey Metrics Comparison Table
| Metric | AVANCE | MOLBIO | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹0.78 | ₹1,438.60 | — |
| 1-Year Price Return | -13.33% | +38.1% | MOLBIO (51.43% higher) |
| 52-Week High | ₹0.90 | ₹1,544.70 | — |
| 52-Week Low | ₹0.77 | ₹1,036.65 | — |
| 30-Day Annualized Volatility | 38.3% | 95.93% | AVANCE (Steadier) |
| 30-Day Average Daily Volume | 5,538,948 | 3,210,458 | AVANCE (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between AVANCE and MOLBIO, which stock gave better returns over the last year?
MOLBIO has outperformed AVANCE over the past 12 months with a gain of 38.1% compared to -13.33%.
Which stock is less volatile: AVANCE or MOLBIO?
AVANCE demonstrated lower price volatility (38.3% annualized) compared to MOLBIO (95.93%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of AVANCE vs MOLBIO?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are AVANCE and MOLBIO direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.